Variant report
Variant | nsv984341 |
---|---|
Chromosome Location | chr16:64770082-64771386 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:4)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:4 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CTCF | chr16:64770340-64770490 | GM12866 | blood: | n/a | n/a |
2 | MAFF | chr16:64770458-64770647 | HepG2 | liver: | n/a | chr16:64770527-64770545 |
3 | MAFK | chr16:64770466-64770615 | HepG2 | liver: | n/a | chr16:64770533-64770544 chr16:64770532-64770543 chr16:64770528-64770544 chr16:64770528-64770543 chr16:64770531-64770545 chr16:64770533-64770544 |
4 | MAFK | chr16:64770421-64770645 | HepG2 | liver: | n/a | chr16:64770533-64770544 chr16:64770532-64770543 chr16:64770528-64770544 chr16:64770528-64770543 chr16:64770531-64770545 chr16:64770533-64770544 |
No data |
No data |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-CDH5-5 | chr16:64770321-64770707 | ENSG00000259859.1 |
2 | lnc-CDH5-5 | chr16:64770691-64771183 | NONHSAT142958 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000260187 | TF binding region |
ENSG00000260068 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs182984534 | chr16:64770108-64770109 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs543368152 | chr16:64770109-64770110 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs77831733 | chr16:64770124-64770125 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs372038071 | chr16:64770200-64770201 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs532184794 | chr16:64770253-64770254 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs138323301 | chr16:64770263-64770264 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs535687665 | chr16:64770267-64770268 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs551992539 | chr16:64770304-64770305 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs545962804 | chr16:64770328-64770329 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
10 | rs200105155 | chr16:64770398-64770399 | Weak transcription | TF binding regionlncRNA | 2 gene(s) | Overlapped CNVs | n/a |
11 | rs565034508 | chr16:64770423-64770424 | Weak transcription | TF binding regionlncRNA | 2 gene(s) | Overlapped CNVs | n/a |
12 | rs142723626 | chr16:64770427-64770428 | Weak transcription | TF binding regionlncRNA | 2 gene(s) | Overlapped CNVs | n/a |
13 | rs144977527 | chr16:64770468-64770469 | Weak transcription | TF binding regionlncRNA | 2 gene(s) | Overlapped CNVs | n/a |
14 | rs138838468 | chr16:64770493-64770494 | Weak transcription | TF binding regionlncRNA | 2 gene(s) | Overlapped CNVs | n/a |
15 | rs12919603 | chr16:64770560-64770561 | Weak transcription | TF binding regionlncRNA | 2 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs7499030 | chr16:64770583-64770584 | Weak transcription | TF binding regionlncRNA | 2 gene(s) | Overlapped CNVs | n/a |
17 | rs116127267 | chr16:64770631-64770632 | Weak transcription | TF binding regionlncRNA | 2 gene(s) | Overlapped CNVs | n/a |
18 | rs150807956 | chr16:64770678-64770679 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
19 | rs149655155 | chr16:64770692-64770693 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
20 | rs369354418 | chr16:64770694-64770695 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
21 | rs372930769 | chr16:64770700-64770701 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
22 | rs202038244 | chr16:64770703-64770704 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
23 | rs377231404 | chr16:64770704-64770705 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
24 | rs145408521 | chr16:64770705-64770706 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
25 | rs71143515 | chr16:64770707-64770708 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
26 | rs374680193 | chr16:64770709-64770710 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
27 | rs368943768 | chr16:64770713-64770714 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
28 | rs553861275 | chr16:64770733-64770734 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
29 | rs565760570 | chr16:64770762-64770763 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
30 | rs231074 | chr16:64770787-64770788 | Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs186045640 | chr16:64770816-64770817 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
32 | rs536544231 | chr16:64770833-64770834 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
33 | rs556858575 | chr16:64770842-64770843 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
34 | rs190064606 | chr16:64770854-64770855 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
35 | rs556827378 | chr16:64770864-64770865 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
36 | rs75765062 | chr16:64770867-64770868 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
37 | rs545570076 | chr16:64770882-64770883 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
38 | rs559154531 | chr16:64771019-64771020 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
39 | rs113593283 | chr16:64771116-64771117 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
40 | rs541185257 | chr16:64771117-64771118 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
41 | rs561292426 | chr16:64771118-64771119 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
42 | rs530053377 | chr16:64771124-64771125 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
43 | rs5817487 | chr16:64771130-64771131 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
44 | rs576672209 | chr16:64771136-64771137 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
45 | rs147153513 | chr16:64771158-64771159 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
46 | rs112224389 | chr16:64771159-64771160 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
47 | rs531723133 | chr16:64771211-64771212 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs7192050 | chr16:64771286-64771287 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs566293167 | chr16:64771334-64771335 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs112689629 | chr16:64771341-64771342 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Schizophrenia | 22958593 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Wilms tumour | 21544195 | CNVD |
Lung cancer | 18438408 | CNVD |
Prostate cancer | 18632612 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16702952 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Prostate cancer | 19242612 | CNVD |
Cancer | 22429812 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Melanoma | 18172304 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Bladder cancer | 21909424 | CNVD |
Breast cancer | 17001317 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Infertility | 21528002 | CNVD |
Breast cancer | 21806811 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Prostate cancer | 16573809 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Autism | 18414403 | CNVD |
Breast cancer | 20409316 | CNVD |
Chordoma | 18071362 | CNVD |
Prostate cancer | 17245344 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Leiomyosarcoma | 16982739 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 21509527 | CNVD |
Cancer | 17440070 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr16:64767600-64772200 | Weak transcription | Muscle Satellite Cultured Cells | -- |
2 | chr16:64770800-64771200 | Enhancers | Osteobl | bone |
3 | chr16:64771200-64772400 | Weak transcription | Osteobl | bone |